Completed consultations we have responded to in 2012


To view our response to consultations click on the links below.

Name of consultation   Originator  
December 2012      
Draft quality indicators for palliative and end of life care   Healthcare Improvement Scotland  
November 2012



UKMi and Medicines Optimisation in England   UKMi  
The next phase: Our consultation on our strategy for 2012 to 2016    CQC  
Performance review of health and care professional regulators   CHRE  
Together for health - delivering end of life care   Welsh Government  
Falsified medicines directive (FMD)   MHRA  
Draft regulations under the National Health Service (Wales) Act 2006 - The National Health Service (Pharmaceutical Services) (Wales) Regulations   NHS Wales  
Controlled drugs (supervision of management and use) regulations 2013   Department of Health  
Implementation of NSF for diabetes in Wales   National Assembly for Wales  
Review of the Shortage Occupation Lists for the UK and Scotland and Creative Occupations   Migration Advisory Committee  
Draft regulations under the National Health Service (Wales) Act 2006 - The National Health Service (Pharmaceutical Services) (Wales) Regulations   Welsh Government  
Safeguarding Choice A draft Assisted Dying Bill for consultation   All Party Parliamentary Group  
Proposed regulations to implement Council Directive 2010/32/EU on preventing sharps injuries in the hospital and healthcare sector.   Health and Safety Executive  
October 2012



Enabling integrated care in Wales   NHS Wales Informatics Service  
Proposals for commissioners to deliver best value   Department of Health  
Protecting and promoting patients’ interests – licensing providers of NHS services   Department of Health  
The development and updating of local formularies
  NICE  
Better care for patients: defining the role of general practice in 2022 – a call for action
  Royal College of GPs  
Early access to medicines scheme in the UK
  MHRA  
Access to medical technologies in Wales
  National Assembly for Wales  
September 2012



Quality in the new health system: Maintaining and improving quality from April 2013
  Department of Health  
Developing our NHS care objectives: A consultation on the draft mandate to the NHS Commissioning Board   Department of Health  
Joint Strategic Needs Assessments and Joint Health and Wellbeing Strategies   Department of Health  
Information: to share or not to share? Information Governance Review   Department of Health  
Integration of health and social care   Scottish Government  
August 2012      
How to change the legal classification of a medicine in the UK   MHRA  
Liberating the NHS: No decision about me, without me. Further consultation on proposals to shared decision-making   Department of Health  
Clarityn Allergy 1mg/ml Syrup (Loratidine) 70ml Pack Size   MHRA  
July 2012      
GPHC draft Amendment to Rules consultation 2012   General Pharmaceutical Council  
Fair Playing Field – for the benefit of patients   Monitor  
Carbon Footprinting Pharmaceuticals and Medical Devices   NHS Sustainable Development Unit  
June 2012  

 

 
Healthy Lives, Healthy People: Towards a workforce strategy for the public health system   Department of Health  

Dyspepsia/GORD

  NICE  
Regulation of Health Professionals   Law Commission  
May 2012  

 

 
Making Things Better – Improving the ways we deal with complaints and concerns about social services in Wales   Welsh Government  
Social Services (Wales) Bill Consultation   Welsh Government  
Modernising pharmacy regulation: A consultation on the draft standards for registered pharmacies   General Pharmaceutical Council  
April 2012  

 

 
Pharmaceutical Services Regulations   Welsh Government  
March 2012      

Call for Evidence on induction for doctors new to practising in the UK

  GMC  

Draft 2012 fees rules for the General Pharmaceutical Council

  General Pharmaceutical Council  
Neutropenic Sepsis   NICE  
ARM 81 Imodium Instants (loperamide hydrochloride) 12 tablet pack size   MHRA  

February 2012
 

 

 
Transposition of Pharmacovigilance Consultation MLX 374   MHRA  
Consultation on potential COF indicators  

NICE

 
Good Medical Practice   GMC  

80 Clarityn Allergy 10mg Tablets (Loratidine) 30 Tablet Pack Size
Request to reclassify a product from P to GSL

  MHRA  
Potential new indicators for the 2013/14 Quality and Outcomes Framework (QOF)   NICE  

January 2012
 

 

 
Implementing a Duty of Candour - a new contractual requirement on providers   Department of Health  
Draft regulations under the Health Act 2009: Market entry by means of pharmaceutical needs assessments and quality and performance  

PNA

 
Service standards on confidentiality  

Faculty of Sexual and Reproduction Healthcare

 
Cost effectiveness and efficiency in health professional regulation  

CHRE

 
Medicines Act consultation  

MHRA

 
NICE's proposals for changes to the process and methods for public health guidance development  

NICE